A detailed history of Ronald Blue Trust, Inc. transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 46 shares of AVNS stock, worth $729. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Holding current value
$729
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$15.58 - $23.61 $716 - $1,086
46 New
46 $0
Q4 2023

Jan 18, 2024

BUY
$17.64 - $22.99 $934 - $1,218
53 New
53 $1,000
Q3 2022

Oct 21, 2022

BUY
$21.56 - $29.59 $86 - $118
4 New
4 $0

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $737M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.